Digestives & Intestinal Remedies - Guatemala

In Guatemala, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$51.34m.
It is projected to experience an annual growth rate of 5.99% (CAGR 2024-2029).
When compared globally, China leads the market with revenues of US$4.41bn in 2024.
Looking at the per capita figures, in 2024, each person in Guatemala generates revenues of US$2.80.
In Guatemala, there is a growing demand for natural digestive remedies, with consumers seeking organic and herbal options for their digestive health.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestives & Intestinal Remedies market in Guatemala is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Guatemala have shifted towards a more health-conscious lifestyle, leading to an increased demand for Digestives & Intestinal Remedies. Guatemalans are becoming more aware of the importance of maintaining a healthy digestive system and are actively seeking products that can help alleviate digestive issues. This shift in customer preferences is driven by a growing awareness of the link between digestive health and overall well-being.Trends in the market also contribute to the growth of the Digestives & Intestinal Remedies market in Guatemala. There is a rising popularity of natural and herbal remedies, as consumers are increasingly seeking products with fewer side effects and a more holistic approach to healthcare. This trend is reflected in the demand for natural and herbal Digestives & Intestinal Remedies in Guatemala.Local special circumstances further support the growth of the Digestives & Intestinal Remedies market in Guatemala. The country has a high prevalence of gastrointestinal diseases and digestive disorders, which creates a large customer base for Digestives & Intestinal Remedies. Additionally, Guatemala has a growing aging population, who are more likely to experience digestive issues and therefore require Digestives & Intestinal Remedies.Underlying macroeconomic factors also play a role in the development of the Digestives & Intestinal Remedies market in Guatemala. The country's improving economic conditions have led to an increase in disposable income, allowing consumers to spend more on healthcare products, including Digestives & Intestinal Remedies. Furthermore, the expanding middle class in Guatemala has a higher purchasing power and is more willing to invest in their health and well-being, driving the demand for Digestives & Intestinal Remedies.In conclusion, the Digestives & Intestinal Remedies market in Guatemala is growing due to changing customer preferences towards a healthier lifestyle, emerging trends in the market such as the demand for natural and herbal remedies, local special circumstances including a high prevalence of digestive disorders, and underlying macroeconomic factors such as improving economic conditions and a growing middle class.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.